207 related articles for article (PubMed ID: 25136067)
1. PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer.
Yao R; Jiang H; Ma Y; Wang L; Wang L; Du J; Hou P; Gao Y; Zhao L; Wang G; Zhang Y; Liu DX; Huang B; Lu J
Cancer Res; 2014 Oct; 74(19):5656-67. PubMed ID: 25136067
[TBL] [Abstract][Full Text] [Related]
2. Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression.
Geng P; Zhang Y; Liu X; Zhang N; Liu Y; Liu X; Lin C; Yan X; Li Z; Wang G; Li Y; Tan J; Liu DX; Huang B; Lu J
FASEB J; 2017 Jun; 31(6):2287-2300. PubMed ID: 28188177
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
4. Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression.
Baldwin RM; Haghandish N; Daneshmand M; Amin S; Paris G; Falls TJ; Bell JC; Islam S; Côté J
Oncotarget; 2015 Feb; 6(5):3013-32. PubMed ID: 25605249
[TBL] [Abstract][Full Text] [Related]
5. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
[TBL] [Abstract][Full Text] [Related]
6. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
7. GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling.
Li Y; Ke Q; Shao Y; Zhu G; Li Y; Geng N; Jin F; Li F
Oncotarget; 2015 Feb; 6(6):4345-56. PubMed ID: 25726523
[TBL] [Abstract][Full Text] [Related]
8. Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling.
Liu Y; Li L; Liu X; Wang Y; Liu L; Peng L; Liu J; Zhang L; Wang G; Li H; Liu DX; Huang B; Lu J; Zhang Y
Elife; 2020 Aug; 9():. PubMed ID: 32844749
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J
Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186
[TBL] [Abstract][Full Text] [Related]
10. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
11. The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
Latorre E; Carelli S; Raimondi I; D'Agostino V; Castiglioni I; Zucal C; Moro G; Luciani A; Ghilardi G; Monti E; Inga A; Di Giulio AM; Gorio A; Provenzani A
Cancer Res; 2016 May; 76(9):2626-36. PubMed ID: 27197265
[TBL] [Abstract][Full Text] [Related]
12. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
13. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
16. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
18. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]